Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics
- PMID: 22791786
- PMCID: PMC3395735
- DOI: 10.1136/bmj.e4505
Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics
Abstract
Objectives: To examine whether rate of reoperation after breast conserving surgery is associated with patients' characteristics and investigate whether reoperation rates vary among English NHS trusts.
Design: Cohort study using patient level data from hospital episode statistics.
Setting: English NHS trusts.
Participants: Adult women who had breast conserving surgery between 1 April 2005 and 31 March 2008.
Main outcome measure: Reoperation rates after primary breast conserving surgery within 3 months, adjusted using logistic regression for tumour type, age, comorbidity, and socioeconomic deprivation. Tumours were grouped by whether a carcinoma in situ component was coded at the time of the primary breast conserving surgery.
Results: 55,297 women had primary breast conserving surgery in 156 NHS trusts during the three year period. 11,032 (20.0%, 95% confidence interval 19.6% to 20.3%) women had at least one reoperation. 10,212 (18.5%, 18.2% to 18.8%) had one reoperation only; of these, 5943 (10.7%, 10.5% to 11.0%) had another breast conserving procedure and 4269 (7.7%, 7.5% to 7.9%) had a mastectomy. Of the 45,793 women with isolated invasive disease, 8229 (18.0%) had at least one reoperation. In comparison, 2803 (29.5%) of the 9504 women with carcinoma in situ had at least one reoperation (adjusted odds ratio 1.9, 95% confidence interval 1.8 to 2.0). Substantial differences were found in the adjusted reoperation rates among the NHS trusts (10th and 90th centiles 12.2% and 30.2%).
Conclusion: One in five women who had breast conserving surgery in England had a reoperation. Reoperation was nearly twice as likely when the tumour had a carcinoma in situ component coded. Women should be informed of this reoperation risk when deciding on the type of surgical treatment of their breast cancer.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing Interest form at
Figures
Comment in
-
Bigger margins are not better in breast conserving surgery.BMJ. 2012 Sep 4;345:e5855. doi: 10.1136/bmj.e5855. BMJ. 2012. PMID: 22951552 No abstract available.
Similar articles
-
Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751. JAMA Surg. 2017. PMID: 28002557 Free PMC article.
-
The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S476-85. doi: 10.1245/s10434-015-4707-9. Epub 2015 Jul 16. Ann Surg Oncol. 2015. PMID: 26178760
-
Surgeon Volume, Patient Age, and Tumor-Related Factors Influence the Need for Re-Excision After Breast-Conserving Surgery.Ann Surg Oncol. 2016 Dec;23(Suppl 5):656-664. doi: 10.1245/s10434-016-5602-8. Epub 2016 Oct 7. Ann Surg Oncol. 2016. PMID: 27718033
-
Impact of routine cavity shave margins on breast cancer re-excision rates.Ann Surg Oncol. 2011 May;18(5):1349-55. doi: 10.1245/s10434-010-1420-6. Epub 2010 Nov 3. Ann Surg Oncol. 2011. PMID: 21046260
-
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery.Cancer Treat Rev. 2021 Mar;94:102158. doi: 10.1016/j.ctrv.2021.102158. Epub 2021 Feb 2. Cancer Treat Rev. 2021. PMID: 33610127 Review.
Cited by
-
Risk Factors for Positive Resection Margins in Breast-Conserving Surgery for Breast Cancer-Retrospective Analysis.Cancers (Basel). 2024 Aug 23;16(17):2930. doi: 10.3390/cancers16172930. Cancers (Basel). 2024. PMID: 39272788 Free PMC article.
-
Preoperative prediction of extensive intraductal component in invasive breast cancer based on intra- and peri-tumoral heterogeneity in high-resolution ultrafast DCE-MRI.Sci Rep. 2024 Jul 29;14(1):17396. doi: 10.1038/s41598-024-68601-6. Sci Rep. 2024. PMID: 39075278 Free PMC article.
-
A handheld device for intra-cavity and ex vivo fluorescence imaging of breast conserving surgery margins with 5-aminolevulinic acid.BMC Biomed Eng. 2024 Jun 1;6(1):5. doi: 10.1186/s42490-024-00079-9. BMC Biomed Eng. 2024. PMID: 38822389 Free PMC article.
-
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.Ann Surg Oncol. 2024 Jun;31(6):3939-3947. doi: 10.1245/s10434-024-15153-8. Epub 2024 Mar 23. Ann Surg Oncol. 2024. PMID: 38520579 Free PMC article.
-
Quality indicators in surgical oncology: systematic review of measures used to compare quality across hospitals.BJS Open. 2024 Mar 1;8(2):zrae009. doi: 10.1093/bjsopen/zrae009. BJS Open. 2024. PMID: 38513280 Free PMC article.
References
-
- Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. - PubMed
-
- American Cancer Society. Breast cancer facts and figures 2009-2010. American Cancer Society, 2009.
-
- Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2008, England. (Series MB1, no 39.) ONS, 2010.
-
- Jeevan R, Browne J, van der Meulen J, Pereira J, Caddy C, Sheppard C, et al. First annual report of the National Mastectomy and Breast Reconstruction Audit 2008. NHS Information Centre, 2008.
-
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous